Literature DB >> 758783

Stability of cisplatin in aqueous solution.

R F Greene, D C Chatterji, P K Hiranaka, J F Gallelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 758783

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN： 0002-9289


× No keyword cloud information.
  14 in total

1.  Serum and tissue levels of platinum after cisplatinum instillation of the rat bladder.

Authors:  H A Wagner; G Groebe; U Engelmann
Journal:  Urol Res       Date:  1988

Review 2.  Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. III. Antimetabolites, tubulin-binding agents, platinum drugs, amsacrine, L-asparaginase, interferons, steroids and other miscellaneous antitumor agents.

Authors:  A G Bosanquet
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

3.  Stability of cisplatin in sodium chloride 0.9% intravenous solution related to the container's material.

Authors:  M Pujol Cubells; J Prat Aixela; V Girona Brumos; S Duran Pou; M Villaronga Flaque
Journal:  Pharm World Sci       Date:  1993-02-19

4.  Interaction of liposome-encapsulated cisplatin with biomolecules.

Authors:  Bharat Baruah; Alexandr Surin
Journal:  J Biol Inorg Chem       Date:  2012-06-07       Impact factor: 3.358

5.  Influence of hydration on ultrafilterable platinum kinetics and kidney function in patients treated with cis-diamminedichloroplatinum(II).

Authors:  M Dumas; C de Gislain; P d'Athis; V Chadoint-Noudeau; A Escousse; J Guerrin; N Autissier
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

6.  Polarographic activity of the antitumor drug cis-dichlorodiammineplatinum (II). The effect of hydrolysis and trans-isomerization of the drug.

Authors:  O Vrána; V Kleinwächter; V Brabec
Journal:  Experientia       Date:  1984-05-15

7.  Stability of the new anticancer platinum analogue 1,2-diaminomethyl-cyclobutane-platinum(II)-lactate (lobaplatin; D19466) in intravenous solutions.

Authors:  H J Guchelaar; D R Uges; P Aulenbacher; E G de Vries; N H Mulder
Journal:  Pharm Res       Date:  1992-06       Impact factor: 4.200

8.  Clinical pharmacology of high-dose cisplatin.

Authors:  B J Corden; R L Fine; R F Ozols; J M Collins
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

9.  Permeability of the rat bladder to Cisplatinum under different conditions: comparison with Mitomycin C and Adriamycin.

Authors:  U Engelmann; G Oelsner; R A Bürger; H Wagner
Journal:  Urol Res       Date:  1983

10.  Cisplatin-induced alterations in the functional spermatogonial stem cell pool and niche in C57/BL/6J mice following a clinically relevant multi-cycle exposure.

Authors:  James G Harman; John H Richburg
Journal:  Toxicol Lett       Date:  2014-04-02       Impact factor: 4.372
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.